Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV (NCT06691243)
Evaluation Of Semaglutide Safety and Tolerability in Adults With Cocaine Use Disorder With and Without HIV
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research study is to find out if semaglutide is safe and well tolerated in adults with cocaine use disorder who do and do not have human immunodeficiency virus (HIV). Participants will complete a screening process and if you are able to participate, you will be assigned to one of two treatment groups: semaglutide or placebo. Participants will: * Visit the clinic once a week for semaglutide or placebo injections * Visit the clinic once every two weeks for labwork, assessments and/or surveys * If consented to optional MRI's, complete two MRI's
Who can join: Review the eligibility criteria below.
Location: Institute of Human Virology at the University of Maryland School of Medicine — Washington D.C., District of Columbia
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Institute of Human Virology at the University of Maryland School of Medicine — Washington D.C., District of Columbia
- Institute of Human Virology at the University of Maryland School of Medicine — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (443) 635-4943
Email: oogbumbadiugha@ihv.umaryland.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cocaine Use Disorder
- Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study — New Haven, Connecticut
- Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study — Pittsburgh, Pennsylvania
- Cocaine Cue-reactivity Incubation Study — New York, New York
- Repurposing Semaglutide for the Treatment of Cocaine Use Disorder — Houston, Texas
- Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder — New York, New York
- Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder — Houston, Texas
Explore by condition: All Cocaine Use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.